HZNP
Calamos Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-100,000
| Closed | -$11.6M | – | 999 |
|
|
2023
Q3 | $11.6M | Sell |
100,000
-128,495
| -56% | -$14.9M | 0.06% | 346 |
|
|
2023
Q2 | $23.5M | Hold |
228,495
| – | – | 0.12% | 220 |
|
|
2023
Q1 | $24.9M | Buy |
228,495
+171,937
| +304% | +$18.8M | 0.12% | 208 |
|
|
2022
Q4 | $6.44M | Buy |
+56,558
| New | +$6.44M | 0.03% | 580 |
|
|
2022
Q1 | – | Sell |
-56,567
| Closed | -$6.1M | – | 1226 |
|
|
2021
Q4 | $6.1M | Sell |
56,567
-22,849
| -29% | -$2.46M | 0.02% | 605 |
|
|
2021
Q3 | $8.7M | Buy |
79,416
+25,738
| +48% | +$2.82M | 0.04% | 438 |
|
|
2021
Q2 | $5.03M | Buy |
53,678
+34,564
| +181% | +$3.24M | 0.02% | 527 |
|
|
2021
Q1 | $1.76M | Sell |
19,114
-712
| -4% | -$65.5K | 0.01% | 682 |
|
|
2020
Q4 | $1.45M | Buy |
19,826
+2,075
| +12% | +$152K | 0.01% | 629 |
|
|
2020
Q3 | $1.38M | Buy |
17,751
+6,038
| +52% | +$469K | 0.01% | 598 |
|
|
2020
Q2 | $651K | Buy |
+11,713
| New | +$651K | ﹤0.01% | 651 |
|
|
2020
Q1 | – | Sell |
-13,400
| Closed | -$485K | – | 806 |
|
|
2019
Q4 | $485K | Hold |
13,400
| – | – | ﹤0.01% | 677 |
|
|
2019
Q3 | $365K | Hold |
13,400
| – | – | ﹤0.01% | 671 |
|
|
2019
Q2 | $322K | Hold |
13,400
| – | – | ﹤0.01% | 680 |
|
|
2019
Q1 | $354K | Buy |
13,400
+400
| +3% | +$10.6K | ﹤0.01% | 593 |
|
|
2018
Q4 | $254K | Buy |
+13,000
| New | +$254K | ﹤0.01% | 597 |
|